<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03083652</url>
  </required_header>
  <id_info>
    <org_study_id>UVIR</org_study_id>
    <nct_id>NCT03083652</nct_id>
  </id_info>
  <brief_title>Effects of Neuromuscular Electrical Stimulation on Exercise Capacity in Respiratory Critically Ill Patients</brief_title>
  <official_title>Effects of Neuromuscular Electrical Stimulation on Exercise Capacity in Respiratory Critically Ill Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Clinic of Barcelona</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital Clinic of Barcelona</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Neuromuscular electrical stimulation (NMES) implemented during the intensive care unit(ICU)&#xD;
      stay may improve exercise capacity and prevent muscular weakness in critically ill patients&#xD;
      with respiratory disease. Main objective: To evaluate, in respiratory critically ill&#xD;
      patients, the effects of a conventional physiotherapy program with or without additional NMES&#xD;
      applied only during the ICU stay on exercise capacity. Design: Randomized, controlled,&#xD;
      double-blind clinical trial on patients (&gt;18yo) with diagnosis on admission of acute or acute&#xD;
      on chronic respiratory disease, on mechanical ventilation (MV) &gt; 72h and expected MV &gt; 24h.&#xD;
      Intervention: Conventional physiotherapy with or without 30-minutes (5days/week) on&#xD;
      quadriceps femoris and gluteus maximus. Patients in the control group will follow the same&#xD;
      protocol but the device will not be activated. Measures: Demographic data, body composition&#xD;
      through bioelectrical impedance analysis (BIA), and functional capacity before admission&#xD;
      through Barthel scale will be registered upon inclusion. Exercise capacity through test&#xD;
      sit-to stand, muscular strength through Medical Research Council (MRC) score and dynamometry,&#xD;
      body composition through BIA, and functional capacity through Barthel scale will be obtained&#xD;
      at ICU and hospital discharge.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 1, 2017</start_date>
  <completion_date type="Anticipated">July 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">March 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Exercise capacity</measure>
    <time_frame>&lt;48h from ICU discharge</time_frame>
    <description>Test sit-to-stand</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Exercise capacity</measure>
    <time_frame>24h before hospital discharge</time_frame>
    <description>Test sit-to-stand</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Muscle strength</measure>
    <time_frame>1st day in which collaboration of the patient is ensured (through standardized 5 questions)</time_frame>
    <description>MRC score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Muscle strength</measure>
    <time_frame>&lt;48 from ICU discharge</time_frame>
    <description>MRC score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Muscle strength</measure>
    <time_frame>24h before hospital discharge</time_frame>
    <description>MRC score</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Muscle strength</measure>
    <time_frame>1st day in which collaboration of the patient is ensured (through standardized 5 questions)</time_frame>
    <description>Dynamometry</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Muscle strength</measure>
    <time_frame>&lt;48 from ICU discharge</time_frame>
    <description>MRC score and dynamometry</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Muscle strength</measure>
    <time_frame>24h before hospital discharge</time_frame>
    <description>MRC score and dynamometry</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body composition (fat free mass)</measure>
    <time_frame>&lt;48h from inclusion</time_frame>
    <description>Bioelectrical impedance</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body composition (fat free mass)</measure>
    <time_frame>&lt;48 from ICU discharge</time_frame>
    <description>Bioelectrical impedance</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Body composition (fat free mass)</measure>
    <time_frame>24h before hospital discharge</time_frame>
    <description>Bioelectrical impedance</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Functional Capacity</measure>
    <time_frame>&lt;24h from inclusion</time_frame>
    <description>Barthel scale</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Functional Capacity</measure>
    <time_frame>24h before hospital discharge</time_frame>
    <description>Barthel scale</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Critical Illness Myopathy</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Conventional physiotherapy with NMEs device not activated</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Intervention</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Conventional physiotherapy with daily 30-minutes NMEs (5 days/week)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Neuromuscular electrical stimulation</intervention_name>
    <description>Neuromuscular electrical stimulation (30 minutes per day, 5 days/week) of the quadriceps femoris and gluteus maximus</description>
    <arm_group_label>Intervention</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Sham</intervention_name>
    <description>Conventional physiotherapy with NMES device NOT activated</description>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Diagnosis at admission: acute or acute on chronic respiratory disease&#xD;
&#xD;
          -  Mechanical ventilation &gt; 72h at inclusion&#xD;
&#xD;
          -  Expected mechanical ventilation &gt; 24h&#xD;
&#xD;
          -  Informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients re-admitted to ICU (no hospital discharge)&#xD;
&#xD;
          -  Exitus or transfer to another service/hospital&#xD;
&#xD;
          -  Respiratory instability [Inspired fraction of oxygen (FIO2) &gt;60% or positive&#xD;
             end-expiratory pressure (PEEP) &gt;10 cmH2O] and/or hemodynamic instability [Mean&#xD;
             arterial pressure ( MAP)&lt;60mmHg although vasoactive drugs] during &gt; 24h.&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Neuromuscular disease before admission&#xD;
&#xD;
          -  Skin lesions&#xD;
&#xD;
          -  Limitation of therapeutic effort&#xD;
&#xD;
          -  Mental and/or physical limitation to understand/realize tests for evaluation&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joan-Daniel Martí, Pt,PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Physiotherapist</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Joan-Daniel Martí, PT,PhD</last_name>
    <phone>0034932275400</phone>
    <phone_ext>4190</phone_ext>
    <email>jd.martibcn@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Javi Martinez, PT</last_name>
    <phone>0034687219761</phone>
    <email>javimagu8@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Unidad de Vigilancia Intensiva Respiratoria (UVIR)</name>
      <address>
        <city>Barcelona</city>
        <zip>08036</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Antoni Torres, Dr</last_name>
      <phone>0034932275400</phone>
      <phone_ext>4190</phone_ext>
      <email>atorres@clinic.ub.es</email>
    </contact>
    <contact_backup>
      <last_name>Miquel Ferrer, Dr</last_name>
      <phone>0034932275400</phone>
      <phone_ext>4190</phone_ext>
      <email>miferrer@clinic.ub.es</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <reference>
    <citation>Abdellaoui A, Préfaut C, Gouzi F, Couillard A, Coisy-Quivy M, Hugon G, Molinari N, Lafontaine T, Jonquet O, Laoudj-Chenivesse D, Hayot M. Skeletal muscle effects of electrostimulation after COPD exacerbation: a pilot study. Eur Respir J. 2011 Oct;38(4):781-8. doi: 10.1183/09031936.00167110. Epub 2011 Feb 24.</citation>
    <PMID>21349913</PMID>
  </reference>
  <results_reference>
    <citation>Zanotti E, Felicetti G, Maini M, Fracchia C. Peripheral muscle strength training in bed-bound patients with COPD receiving mechanical ventilation: effect of electrical stimulation. Chest. 2003 Jul;124(1):292-6.</citation>
    <PMID>12853536</PMID>
  </results_reference>
  <verification_date>August 2020</verification_date>
  <study_first_submitted>February 28, 2017</study_first_submitted>
  <study_first_submitted_qc>March 13, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">March 20, 2017</study_first_posted>
  <last_update_submitted>August 11, 2020</last_update_submitted>
  <last_update_submitted_qc>August 11, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">August 12, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital Clinic of Barcelona</investigator_affiliation>
    <investigator_full_name>Joan-Daniel Martí Romeu</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>physiotherapy</keyword>
  <keyword>neuromuscular electrical stimulation</keyword>
  <keyword>exercise capacity</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Critical Illness</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

